Barr Claravis 30 Mg Dose Will Compete With Ranbaxy’s Isotretinoin Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche markets Accutane in 10 mg, 20 mg and 40 mg doses only.
You may also be interested in...
Cipher Receives “Approvable” Letter For CIP-Isotretinoin
FDA letter appears to resolve questions about the appropriate pathway for the acne medication.
Accutane iPLEDGE Debut On Track Despite Calls For Delay
FDA confirmed that it would not delay the March 1 implementation of the isotretinoin risk management program.
Biogen ‘Ready To Launch’ Aducanumab If It Gets The Chance
The company has identified 600 sites of care to treat Alzheimer's patients with aducanumab in the US and is confident on its pricing strategy, management said.